Skip to main content

Table 3 Safety and incidence of AE and SAE in 25 and 40 IU/kg groups.

From: A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal

 

4-factor PCC regimen

 
 

25 IU/kg

(n = 29)

40 IU/kg

(n = 30)

P value

Death

4 (13.8)

6 (20.0)

0.731

Patients with at least one AE

24 (82.8)

25 (83.3)

1.000

Patients with at least one SAE

11 (37.9)

12 (40.0)

0.871

Patients with at least one TE

2 (6.9)

2 (6.7)

1.000

  1. Results are expressed as n (%). AE, adverse effects; PCC, prothrombin complex concentrate; SAE, serious adverse effects; TE, thrombotic event.